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Decavanadate induced rat liver mitochondrial depolarization at very low concentrations, half-depolarization with 39 nM decavana-
date, while it was needed a 130-fold higher concentration of monomeric vanadate (5 lM) to induce the same eﬀect. Decavanadate also
inhibits mitochondrial repolarization induced by reduced glutathione in vitro, with an inhibition constant of 1 lM, whereas no eﬀect was
observed up to 100 lM of monomeric vanadate. The oxygen consumption by mitochondria is also inhibited by lower decavanadate than
monomeric vanadate concentrations, i.e. 50% inhibition is attained with 99 nM decavanadate and 10 lM monomeric vanadate. Thus,
decavanadate is stronger as mitochondrial depolarization agent than as inhibitor of mitochondrial oxygen consumption. Up to 5 lM,
decavanadate does not alter mitochondrial NADH levels nor inhibit neither FOF1-ATPase nor cytochrome c oxidase activity, but it
induces changes in the redox steady-state of mitochondrial b-type cytochromes (complex III). NMR spectra showed that decameric van-
adate is the predominant vanadate species in decavanadate solutions. It is concluded that decavanadate is much more potent mitochon-
drial depolarization agent and a more potent inhibitor of mitochondrial oxygen consumption than monomeric vanadate, pointing out
the importance to take into account the contribution of higher oligomeric species of vanadium for the biological eﬀects of vanadate
solutions.
 2007 Elsevier Inc. All rights reserved.
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Most of the toxicological studies of vanadate in biolog-
ical systems do not take in consideration the contribution
of vanadate oligomers, such as the decameric vanadate spe-
cies (V10). Decameric vanadate, composed by fused V(V)
octahedra, has an ellipsoid like structure with a major
and minor axis of approximately 7 and 6 A˚, respectively
[1]. In previous studies [2–8], we have demonstrated that0162-0134/$ - see front matter  2007 Elsevier Inc. All rights reserved.
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decomposition is slow enough to allow studying diﬀerential
eﬀects between decameric and monomeric vanadate not
only in vitro but also in vivo. Furthermore, decameric van-
adate is stabilized upon interaction with cytoskeleton and
membrane proteins, while it aﬀects calcium translocation
by the sarcoplasmic reticulum calcium pump and it pre-
vents actin polymerization [9].
Vanadate is known to aﬀect mitochondrial respiration by
altering electron transfer between complexes III and IV [10].
Several studies have associated vanadium toxicity with its
capacity to induce the formation of reactive oxygen species
(ROS), probably by interacting with mitochondrial redox
centres [11,12]. Along this line of thinking, DeMaster and
Mitchell [10] pointed out that vanadate blocked electron
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b1 and cytochrome c, which caused inhibition of the oxida-
tion of NADH-linked substrates and succinate [13,14].
Mitochondrial succinate dehydrogenase had also been
reported to be inhibited by vanadium (V) ions [15], as well
as the ATP-dependent succinyl-CoA synthetase (A-SCS)
from rat brain mitochondria [16,17]. Studies involving other
vanadate species, instead of only monomeric vanadate (V1),
have shown that decavanadate: (i) stimulates oxidation of
NADH by rat erythrocyte plasma membrane [18,19] and
by rat liver microsomes [20,21]; (ii) enhances cytochrome
c reduction [22]; (iii) exhibits a-adrenergic agonist activity
in rat aortic rings [23]; and (iv) is reduced by NADP+-spe-
ciﬁc isocitrate dehydrogenase (IDH) [22].
As the eﬀects of decameric vanadate on mitochondrial
membrane potential and oxygen consumption have not
been described, its contribution to the impairment of
mitochondrial function associated with vanadium citotox-
icity (Soares et al., unpublished results) is still an unre-
solved issue. This work addresses these points using rat
hepatic mitochondria, aiming to elucidate the relative sen-
sitivity of mitochondrial functions to decameric and
monomeric vanadate. It is shown for the ﬁrst time that
decameric vanadate is a very strong mitochondrial depo-
larizing agent and also a potent inhibitor of mitochon-
drial oxygen consumption.
2. Materials and methods
2.1. Vanadate solutions
Metavanadate stock solution (50 mM, pH 6.7) was pre-
pared from ammonium metavanadate (NH4VO3). Deca-
vanadate stock solution was obtained by adjusting the
pH of the former solution to 4.0 [24]. Vanadate oligomers
composition of decavanadate and metavanadate solutions
upon dilution into the mitochondrial respiration buﬀer
(0.2 M sucrose, 5 mM KH2PO4, 10 mM KCl, 5 mMMgCl2
and 10 mM Tris–HCl, pH 7.4 plus 5 mM pyruvate and
0.5 mM malate), in the absence or in the presence of
5 mM glutathione (GSH), was measured by 51V nuclear
magnetic resonance spectroscopy in a Bruker AM-400
spectrometer at 105.2 MHz equipped with a 5-mm multi-
nuclear inverse probe, by using a 90 pulse Fourier trans-
form technique, as previously reported [4,7,8].
2.2. Animals
Adult (3-month-old) male rats (Rattus norwegicus),
weighing 200–250 g, from an inbred Wistar strain were
obtained from the Animal Services of the University of
Extremadura, Badajoz (Spain). Animals were provided
within a standard chow with free access to water and food.
Animals were fasted overnight with a free access to water
before sacriﬁced. All the experiments on animals follow
the National Research Council’s guide for the care and
use of laboratory animals.2.3. Experimental procedures
2.3.1. Mitochondria isolation
Mitochondria were isolated from rat liver by diﬀerential
centrifugation, as described by Johnson and Lardy [25].
Mitochondria samples were aliquoted and stored at
80 C, immediately after their preparation in order to
prevent in vitro aging, and used within 2 weeks. Protein
concentration was determined with the Bradford’s assay
[26], using bovine serum albumin as protein standard.
Rat hepatic mitochondria have succinate dehydrogenase
and FOF1-ATPase activities of 2120 ± 453 and 1115 ± 64
nmol/min/mg protein, respectively, values that falls within
the range reported for these enzymes activities in mamma-
lian mitochondria [27].
2.3.2. Mitochondrial enzyme activities
Succinate dehydrogenase (SDH) activity was measured
at 37 C from potassium ferricyanide reduction [28].
FOF1-ATPase activity was measured spectrophotometri-
cally using the coupled enzyme pyruvate kinase/lactate
dehydrogenase assay [29]. Vanadate solutions eﬀects on
mitochondrial FOF1-ATPase activity was assayed, with
decameric (V10) or monomeric (V1) vanadate species up
to 20 lM (total vanadium), in order to avoid the non-
enzymatic NADH oxidation, observed in the presence
of vanadium concentrations above 50 lM (data not
shown).
Decavanadate and metavanadate eﬀects on mitochon-
drial cytochrome c oxidase activity was analysed by the
spectroscopic method of Smith [30]. The rate of oxidation
of cytochrome c was measured by following the decrease
in the absorbance of its a-band at 550 nm [31]. The stan-
dard reaction mixture containing 10 mM phosphate buﬀer
(pH 7.0) plus 14% ferrocytochrome c and the absorbance
change at 550 nm was measured at 37 C, in the absence
or in the presence of vanadate, after addition of 200 lg
mitochondria protein per ml.
2.3.3. Measurement of mitochondrial membrane potential
Mitochondrial membrane potential was monitored
using 5,5 0,6,6 0-tetrachloro-1,1 0,3,3 0-tetraethylbenzimidazol-
carbocyanine iodide (JC-1), a ﬂuorescent indicator of
membrane potential [32].
Mitochondria (15 lg protein/ml) were loaded with
0.6 lM JC-1 by incubation at 37 C for 15 min [33] and
ﬂuorescence experiments were performed under continu-
ous stirring with a Perkin-Elmer 650–40 ﬂuorescence
spectrophotometer (Perkin–Elmer, Foster City, CA,
USA). JC-1 monomer (green) ﬂuorescence was measured
by excitation at 490 nm and recording the emission near
532 nm. JC-1 aggregate (red) ﬂuorescence was measured
by excitation at 490 nm and recording the emission at
595 nm. The eﬀect of vanadate solutions on mitochon-
drial membrane potential was determined by adding dif-
ferent vanadate concentration up to 50 lM (total
vanadium). Assays were standardized with a known
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2,4(a)-Dinitrophenol (DNP). The ratio of JC-1 aggregate
to monomer intensity was calculated and the degree of
depolarization estimated (Eq. (1)). The value of the ratio
(F595/F532) for monomeric JC-1, which corresponds to
totally depolarized mitochondria, was 1.52 ± 0.47. An
increase in this ratio is indicative of increase in membrane
potential, whereas a decrease in the ratio is indicative of
decrease in membrane potential [34]
Depolarizationð%Þ ¼ Rt  R0
R0  RþDNP  100 ð1Þ
Rt = ratio of JC-1 aggregate to monomer intensity after
incubation (60 min)
R0 = initial ratio of JC-1 aggregate to monomer intensity
(time = 0 min)
R+DNP = ratio of JC-1 aggregate to monomer intensity 1 h
after DNP addition2.3.4. Determination of mitochondrial oxygen consumption
Oxygen consumption of mitochondria was measured
polarographically with a Hansatech Oxygen Electrode
equipped with a Clark-type oxygen electrode and a poten-
tiometric recorder. Respiration of freshly isolated rat hepa-
tic mitochondria at a ﬁnal concentration 2 mg/ml was
measured at 37 C, in the standard reaction mixture con-
tained (in mM): 250 sucrose, 5 KH2PO4, 10 KCl, 5 MgCl2,
10 Tris–HCl (pH 7.4) and supplemented with the following
substrate combination: 0.5 mM malate plus 5 mM pyru-
vate. Respiration rates were measured in the absence and
presence of 200 lM ADP. V10 eﬀects on mitochondrial res-
piration were assayed upon incubation with vanadate con-
centrations of both vanadate stock solutions below 25 lM
(total vanadium). At the end of each run, an inhibitor of the
mitochondrial electron transport chain – 40 lM rotenone –
was added and the new rate of respiration measured. In the
presence of rotenone, no oxygen consumption was
obtained. The oxygen concentration in buﬀer was 219 nmol
of O2 per ml after standard calibration in water at 37 C.
Oxygen consumption rates were expressed as nmol O/
min/mg protein. Respiratory control ratio, as described
by Chance and Williams [35], and ADP/O ratio were calcu-
lated as previously reported [36].
2.3.5. Measurement of NADH content in mitochondria
NADH content in isolated mitochondria exposed to
vanadate concentrations up to 20 lM (total vanadium),
was determined through ﬂuorimetric measurement of
NADH in the neutralized alkaline mitochondrial extracts
[37]. Fluorescence signals were recorded (k excitation:
340 nm; k emission: 460 nm) in a medium containing:
0.1 M phosphate plus 0.1 M KCl (pH 7.5), 1 mM pyruvate
and 1.375 IU lactate dehydrogenase, and the NADH con-
centration was calculated using a ﬂuorescence calibration
curve obtained with known concentrations of this pyridine
nucleotide.2.3.6. Reactive oxygen species production
Vanadate eﬀects on reactive oxygen species (ROS) pro-
duction, namely superoxide anion ðO2 Þ production, was
measured at pH 7.4 and 37 C using the ﬂuorescent dye
dihydroethidium (DHE), as in Budd et al. [38]. The eﬀect
of an electron donor (NADH) on ROS production was
tested separately in the presence and absence of vanadate
(concentrations up to 50 lM total vanadium). O2 produc-
tion was calculated from 10 lMDHE ﬂuorescence observed
(k excitation: 473 nm; k emission: 600 nm) in presence of
0.5 mM malate plus 5 mM pyruvate or 250 lM NADH.
2.3.7. Cytochrome b redox state
The overall spectrum of mitochondria was acquired by
diﬀerential spectroscopy in a Hewlett Packard 8451 A
diode array spectrophotometer, a single-beam, micropro-
cessor-controlled spectrophotometer. The absorbance
readings at all wavelengths of the overall spectrum (every
2 nm from 400 to 600 nm) were obtained simultaneously.
The incubation medium contained mitochondrial respira-
tion buﬀer (Section 2.1), 0.5 mM malate plus 5 mM pyru-
vate and 1 mg mitochondria protein per ml. The electron
chain spectrum and its redox changes upon incubation with
decavanadate or metavanadate solutions were compared
with a control situation (in the absence of vanadate).
2.4. Statistical analysis
All parameters studied are present as average and stan-
dard deviation of measurements taken at least in three sep-
arate experiments. Statistical signiﬁcance of the data was
calculated by Mann–Whitney non-parametric test. Diﬀer-
ences from control were considered signiﬁcant at P < 0.05.
3. Results and discussion
3.1. Eﬀect of decavanadate on mitochondrial membrane
potential
In the absence of GSH the membrane potential remains
stable for 10–15 min and then slowly decays (Fig. 1a), thus,
allowing to determine the eﬀects of decameric (V10) and
monomeric (V1) vanadate on mitochondrial membrane
potential. Fig. 1b shows that 10 min exposure to increasing
vanadate concentrations leads to increasing mitochondrial
depolarization. V10 induced mitochondrial depolarization
in rat hepatic mitochondria at very low concentrations
with an IC50 of 38.7 ± 10.2 nM, while 5.4 ± 2.5 lM V1
was needed to induce a 50% depolarization in rat liver
mitochondria.
3.1.1. Decavanadate eﬀect on GSH-induced mitochondrial
membrane repolarization in respiration buﬀer
Addition of a physiological concentration of GSH
(5 mM) to the mitochondria respiration buﬀer after 60 min,
i.e. to depolarized mitochondria, induced mitochondrial
repolarization in vitro with a half-time of 5 min, reaching
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Fig. 1. Mitochondrial membrane depolarization by decameric (V10) and
monomeric (V1) vanadate species. Time-induced mitochondrial membrane
depolarization (a) in the absence of a physiological glutathione (GSH)
concentration; V10- (solid circles) and V1-induced (open circles) mito-
chondrial membrane depolarization (%) on rat liver mitochondria (15 lg
protein/ml), in the presence of 5 mM GSH (b). The assay was performed
at 37 C, in a reaction medium containing the corresponding mitochon-
drial isolation buﬀer (250 mM sucrose; 5 mM Tris pH 7.4 and 1 mM
EGTA) supplemented with 150 mM KCl, 10 mM Tris pH 7.4, 0.5 mM
malate plus 5 mM pyruvate and 0.6 lM 5,5 0,6,6 0-tetrachloro-1,1 0,3,3 0-
tetraethylbenzimidazolcarbocyanine iodide (JC-1), a ﬂuorescent indicator
of membrane potential. Values are present as means ± SD (n = 3).
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Fig. 2. Kinetics of mitochondrial membrane repolarization. Kinetics of
mitochondrial membrane repolarization with physiological glutathione
(GSH) concentration (5 mM) (solid triangles); GSH-induced repolariza-
tion after mitochondrial membrane depolarization by 1 lM decameric
vanadate (V10) (solid circles) or 100 lM monomeric vanadate (V1) (open
circles) in respiration buﬀer minus GSH. Repolarization was monitored at
37 C in 250 mM sucrose, 15 mM Tris pH 7.4, 1 mM EGTA, 150 mM
KCl, 0.5 mM malate plus 5 mM pyruvate, 15 lg hepatic mitochondria
protein/ml and 0.6 lM JC-1 membrane potential ﬂuorescent indicator.
Values are present as means ± SD (n = 3).
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inducing membrane repolarization, GSH confers stability
of the mitochondrial membrane potential with a half-life
time of 90 min (data not shown).
From steady-state values of the control (2.75), V10
(2.0) and V1 (3.0) we determined the eﬀects induced
by the vanadate solutions on membrane repolarization,
considering the approx. basal value of 1.25 observed at
time zero, for the addition of GSH. In this sense, for
1 lM V10 we obtained an inhibition of almost 50%,
whereas in the presence of 100 lM V1 the mitochondrial
repolarization was stimulated by 10% (Fig. 2).3.2. Eﬀect of decavanadate on mitochondrial oxygen
consumption
With pyruvate plus malate, the basal respiration rate of
our preparations of rat hepatic mitochondria was 39 and
20 ng atom O/min/mg protein for State 3 and 4, respec-tively. It was observed that V10 inhibits mitochondrial res-
piration at State 3 (ADP-stimulated) as shown by a
decrease in oxygen consumption measured in intact liver
mitochondria (Fig. 3a). V10 is nearly 100-fold more potent
than V1 as inhibitor of oxygen consumption in hepatic
mitochondria, as shown by their IC50 values, 98.5 ± 5.1
nM for V10 and 9.7 ± 1.4 lM for V1 (Fig. 3a).
Both vanadate solutions promote mitochondrial respira-
tion inhibition without uncoupling mitochondria, as the
respiratory control ratio (RCR) was not aﬀected
(Fig. 3b). The RCR values for rat liver coupled mitochon-
dria respiring on pyruvate and malate were 5.1 ± 0.1, in the
absence or presence of both vanadates species (Fig. 3b).
These results are in good agreement with those reported
in [10], where there was found no uncoupling of oxidative
phosphorylation in intact rat liver mitochondria and a
small apparent increase in ADP/O rates, due to an inhibi-
tion of adenylate kinase activity by V10 (1 mM). It is to be
noted that our results leads to ADP/O ratios for pyruvate
and malate of 2.4 ± 0.7, both in the absence or presence of
V10 or V1, a value which is close to the theoretical value of
3 [36].3.3. Decavanadate eﬀects on mitochondrial FOF1-ATPase
activity, NADH levels and reactive oxygen species
production
Rat hepatic mitochondria FOF1-ATPase exhibited a
basal control activity of 1115 ± 64 nmol/min/mg protein.
Up to 20 lM, no eﬀects were observed for V10 or V1 on this
mitochondrial ATPase activity, in agreement with several
studies using higher vanadate concentrations (100 lM total
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Fig. 3. Decameric vanadate (V10) and monomeric vanadate (V1) inhib-
itory eﬀects on mitochondrial respiration measured with an oxygen
electrode. Eﬀect of V10 (solid circles) and V1 (open circles) (up to 25 lM
total vanadium, namely 2.5 lMV10) on rat liver respiring mitochondria (2
mg protein/ml) on pyruvate plus malate. Oxygen consumption (%) (a) and
respiratory ratio control (RCR) (b) on hepatic intact mitochondria were
recorded in mitochondrial respiration buﬀer containing 0.2 M sucrose,
5 mM KH2PO4, 10 mM KCl, 5 mM MgCl2 and 10 mM Tris pH 7.4, to a
ﬁnal volume of 2 ml (5 mM pyruvate plus 0.5 mM malate were added as
substrate). Values are present as means ± SD (n = 3).
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Fig. 4. Rate of reactive oxygen species (ROS) production, namely
superoxide anion ðO2 Þ, upon exposure to decameric (V10) and monomeric
(V1) vanadate species. Eﬀect of V10 (solid circles) and V1 (open circles) (up
to 50 lM total vanadium) on O2 production (%) minus NADH (A) and
in the presence of NADH (B) in rat liver mitochondria (15 lg protein/ml).
The assay was performed at 37 C, in the presence of the corresponding
mitochondrial isolation buﬀer (250 mM sucrose; 5 mM Tris pH 7.4 and
1 mM EGTA) supplemented with 150 mM KCl, 10 mM Tris pH 7.4,
0.5 mM malate plus 5 mM pyruvate (a) or 250 lM NADH (b) and 10 lM
dihydroethidium (DHE) ﬂuorescent probe. Values are present as
means ± SD (n = 3).
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not aﬀected by the vanadate solutions.
Additionally, both V10 and V1 had no eﬀect on reactive
oxygen species (ROS) production, namely O2 , on rat hepa-
tic mitochondria (Fig. 4a), except when NADH is used as
an electron transfer chain substrate (Fig. 4b). Under the
latter experimental conditions, V10 decreases O

2 produc-
tion by 40% (5 lM) whereas 10-fold V1 (50 lM) is need
to induce a similar eﬀect. This decrease in O2 formation
is, at least in part, due to the observed inhibition in mito-
chondrial respiration, once it was proved that O2 originat-
ing from respiring mitochondria is a stoichiometric
precursor of mitochondrial hydrogen peroxide (H2O2).
Recently, it has been described that in rat brain mito-
chondria even a very small decrease of mitochondrial
membrane potential, which decreases mitochondrial res-piration, results in a strong inhibition of ROS formation
[41]. Therefore, ROS formation is also a function of
mitochondrial membrane potential. Since V10 strongly
depolarized mitochondria, the capacity to produce O2
will be depressed and, in fact, the results obtained for
V10 are fully consistent with this statement (Fig. 4b).
Therefore, both V10-induced mitochondrial depolariza-
tion and decrease in mitochondrial oxygen consumption
can account for its antioxidant eﬀect, monitored as par-
tial inhibition of ROS production.3.4. Characterization of vanadate solutions: NMR studies
In order to precisely deﬁne what vanadate species
are promoting the observed eﬀects in isolated rat liver
794 S.S. Soares et al. / Journal of Inorganic Biochemistry 101 (2007) 789–796mitochondria, the vanadate species composition in vana-
date solutions was analyzed by 51V NMR spectroscopy.
It was observed that the spectra of decavanadate solution,
after dilution in the mitochondrial respiration buﬀer (Sec-
tion 2.1) – 5 mM total vanadium, at pH 7.0 – contained
only decameric species once the three signals from V10,
attributed to the three vanadium atoms of the decavana-
date structure, as described elsewhere [24], are observed:
V10A at 516 ppm, V10B at 499 ppm and V10C at
425 ppm (Fig. 5a). Conversely, in the metavanadate solu-
tion (Fig. 5c), 5 mM total vanadium, were detected mono-
(V1), di- (V2) and also tetrameric (V4) vanadate species,
respectively, at 561 ppm, 575 ppm and at 579 ppm.
Two new vanadate signals were clearly identiﬁed in the
51V NMR spectra of vanadate solution diluted in mito-
chondrial respiration buﬀer (Fig. 5c): these bound vana-
date signals observed at 555 ppm (C1) and 540 ppm
(C2) are due to the presence of sucrose in the medium,
being C1 and C2 due to complexes of vanadate with geo-
metric isomers of sucrose [42].
Millimolar GSH concentrations, the concentration
range of GSH reported for most mammalian tissues, is
known to reduce millimolar vanadate to vanadium(IV) at
a physiological pH 7 [43]. In the presence of 5 mM GSH,
used in the mitochondrial membrane potential studies,
V10 signals suﬀer a decrease in intensity without broaden-
ing of the peaks (Fig. 5b). This decrease in the intensity
of the decameric vanadate signals is due to V10 deoligomer-
ization since it was observed that GSH induces it decompo-
sition (not shown). In fact, a small peak at 561 ppm, can
be observed upon addition of 5 mM GSH (Fig. 5d). The
eventual presence of vanadyl paramagnetic species in solu-
tion would induce a broadening of NMR V10 signals
besides an increase of the signal/noise ratio (that was not
observed, see Fig. 5b). At physiological pH, vanadate
NMR signals observed for the metavanadate solution
remain unchanged upon addition of GSH to the medium
(Fig. 5d), although it has been described that in the pres-
ence of GSH, vanadate is reduced to vanadyl and it
becomes bound to haemoglobin [43].Fig. 5. 105.2 MHz 51V NMR spectra, at room temperature, of decavanadate
total vanadium) in mitochondrial respiration buﬀer (see Section 2.1) plus 5 mM
and d) of 5 mM glutathione (GSH). All spectra were acquired in the presence o
decameric species. In the presence of GSH, new vanadate NMR signals, C1 a
signals correspond, respectively, to monomeric and dimeric vanadate specie
tetrameric vanadate species. C1 and C2 stand for sucrose:vanadate complexes.In the presence of 1 mg/ml mitochondria, neither the
concentration of the diﬀerent vanadate species nor the ratio
between vanadate oligomers in both solutions were chan-
ged (data not shown). Therefore, vanadate species do not
disappear under the conditions used for the kinetic studies
reported in this work, allowing correlating its in vitro eﬀects
on mitochondrial integrity and functionality. In con-
trast with metavanadate solutions, which contain labile
oxovanadates interconverting each other within the milli-
seconds time scale, decameric vanadate present in deca-
vanadate solutions has very slow decomposition kinetics
upon dilution.
The kinetics of deoligomerization, assessed by measure-
ments of the absorption at 400 nm, is a ﬁrst order kinetics
[8], with a half-life time up to 3 h (measured at 37 C with
100 lM decameric vanadate species in mitochondrial respi-
ration buﬀer). Therefore, at the V10 concentrations used in
the enzymatic studies the decavanadate solutions contain
decameric species whereas metavanadate solutions up to
100 lM mostly contain monomeric vanadate species, as
described elsewhere [42].
3.5. Decavanadate eﬀects on complex III
3.5.1. Decavanadate eﬀects on cytochrome c oxidase
To experimentally test the possibility that the mecha-
nism of V10-induced inhibition of the electron transport
chain could be due to inhibition of complex III, at ﬁrst
we measured the eﬀect of V10 on the redox state of ferrocy-
tochrome c. It was observed that at pH 7.0, either V10 or V1
did not induce changes on the redox state of puriﬁed ferro-
cytochrome c. Moreover, neither V10 nor V1 alter the cyto-
chrome c oxidase activity of rat liver mitochondria
(measured as indicated in Section 2.1). These results are
in good agreement with the major conclusion reached in
Kalyani and Ramasarma [21], namely, that the oxidation
of reduced cytochrome c during vanadate-stimulated
NADH oxidation required the presence of both vanadate
and H2O2, since the latter oxidation is produced by the
hydroxyl radicals formed in vanadate/H2O2 mixtures.(pH 7.0) (a and b) and metavanadate (pH 7.0) (c and d) solutions (5 mM
pyruvate and 0.5 mMmalate, in the absence (a and c) or in the presence (b
f 10% D2O. V10A, V10B and V10C are signals of vanadium atoms from the
nd C2, are observed in metavanadate spectrum (C e D). V1 and V2 NMR
s regardless of the protonation state, whereas V4 corresponds to cyclic
2,
gl
hy
co
on
ox
en
am
Wavelength (nm)
460 480 500 520 540 560 580 600
Wavelength (nm)
460 480 500 520 540 560 580 600
A
bs
or
ba
nc
e
-0.15
-0.10
-0.05
0.00
0.05
0.10
0.15
Wavelength (nm)
460 480 500 520 540 560 580 600
a b c
Fig. 6. Decameric vanadate (V10)-induced redox changes on cytochromes spectra of the respiratory chain. The ﬁgure shows the diﬀerential spectrum of rat
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(b) or monomeric vanadate, V1 (c) on mitochondrial respiration buﬀer (see Section 2.1). In the presence of V10 (B) there are large absorbance changes in
the wavelength range that monitors the redox state of mitochondrial cytochromes b (500–550 nm) with respect to control (a). The arrows point at the
wavelengths reported for the absorbance peaks of mitochondrial cytochromes b [46]. Values are present as means ± SD (n = 3).
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Once excluded that V10-induced mitochondrial depolar-
ization and inhibition of oxygen consumption can be
rationalized in terms of inhibition of cytochrome oxidase,
we considered the possibility that the redox state of mito-
chondrial cytochromes b could be aﬀected by decavana-
date. To this end we recorded the eﬀects of V10 and V1
(20 lM total vanadium) on the diﬀerential spectrum of
mitochondria in the presence and absence of the respira-
tion substrates (pyruvate plus malate). The changes in
the 500–550 nm wavelength range induced by V10 pointed
out that the cytochrome b redox state is altered by V10,
but not with V1, suggesting that mitochondrial complex
III (ubiquinol:cytochrome c oxidoreductase) is a target
for decameric vanadate (Fig. 6). Therefore, V10 induces
antimycin A-like inhibition (speciﬁc inhibitor of complex
III) in mitochondria respiratory chain.pr
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te4. Concluding remarks
Previous in vivo studies allowed us to suggest that mito-
chondria is a subcellular target of vanadate when vanadium
is administered as V10 [2,5–8]. In the present work, it is
shown for the ﬁrst time that V10 is 10 to 100-fold more
potent than V1 as mitochondrial depolarization agent and
as inhibitor of oxygen consumption by mitochondria.
Moreover, V10-induced mitochondrial depolarization is
observed at V10 concentrations lower than those required
to produce a signiﬁcant inhibition of oxygen consumption
by mitochondria. As membrane hyperpolarization has been
described to be an early mitochondrial response during
apoptosis [44,45], these results suggest to explore the useful-
ness of V10 as an anti-apoptotic agent in future studies.
These eﬀects of V10 are likely due to V10-induced changes
in the redox steady-state of cytochrome b (complex III), asneither the mitochondrial NADH level, nor cytochrome
oxidase, nor FOF1-ATPase activities are signiﬁcantly altered
by V10. Furthermore, it is concluded that decameric vana-
date strongly aﬀects mitochondria bioenergetics through
diﬀerent toxicity mechanisms than monomeric vanadate.
5. Abbreviations
DHE dihydroethidium
DNP 4(a)-dinitrophenol
GSH utathione reduced form
H2O2 drogen peroxide
IC50 ncentration that produced 50% of the eﬀect
mitochondria membrane potential, on
ygen consumption or that inhibits 50% an
zyme activityIU ount of enzyme that release 1 lmole of
oduct per minuteJC-1 5 0,6,6 0-tetrachloro-1,1 0,3,
-tetraethylbenzimidazolcarbocyanine iodideNADH -nicotinamide adenine dinucleotide
educed form)O2 peroxide anion
ROS active oxygen species
SDH ccinate dehydrogenase
Tris is(hydroxymethyl)aminomethane
V1 thovanadate or monomeric vanadate species
V10 cameric vanadate species
V2 meric vanadate species
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